SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891554-02-001538
Filing Date
2002-03-26
Accepted
2002-03-26 00:00:00
Documents
14
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d50062_10k.txt 10-K 241493
3 AMENDED AND RESTATED BYLAWS d50062ex3_2.txt EX-3.2 89006
4 EMPLOYMENT AGREEMENT d50062ex10_4.txt EX-10.4 27781
5 AMENDED EMPLOYMENT AGREEMENT d50062ex10_5.txt EX-10.5 31995
6 LICENSE AGREEMENT d50062ex10_8.txt EX-10.8 107002
7 RESEARCH AGREEMENT d50062ex10_9.txt EX-10.9 28899
8 EMPLOYMENT AGREEMENT d50062ex10_29.txt EX-10.29 40347
9 EMPLOYMENT AGREEMENT d50062ex10_30.txt EX-10.30 34290
10 EMPLOYMENT AGREEMENT d50062ex10_31.txt EX-10.31 35927
11 EMPLOYMENT AGREEMENT d50062ex10_32.txt EX-10.32 40409
12 MANAGEMENT SERVICES AGREEMENT d50062ex10_33.txt EX-10.33 12725
13 SUBLEASE AGREEMENT d50062ex10_34.txt EX-10.34 31641
14 SUBSIDIARIES OF THE REGISTRANT d50062ex21_1.txt EX-21 335
15 LETTER OF CONSENT d50062ex23_1.txt EX-23.1 884
  Complete submission text file 0000891554-02-001538.txt   725741
Mailing Address
Business Address 216 JAFFA ROAD SHAAREI HAIR JERUSALEM ISRAEL 94383 9722534997
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 02586874
SIC: 2834 Pharmaceutical Preparations